Laurion Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-17,800
Closed -$3.24M 757
2020
Q4
$3.24M Sell
17,800
-44,300
-71% -$7.53M 0.03% 292
2020
Q3
$10.4M Sell
62,100
-54,700
-47% -$9.21M 0.12% 163
2020
Q2
$19M Buy
+116,800
New +$20.9M 0.21% 119
2017
Q4
Sell
-32,300
Closed -$4.38M 1565
2017
Q3
$4.38M Buy
32,300
+27,000
+509% +$3.41M 0.02% 548
2017
Q2
$663K Sell
5,300
-32,300
-86% -$3.86M ﹤0.01% 1164
2017
Q1
$4.47M Sell
37,600
-21,100
-36% -$2.54M 0.03% 443
2016
Q4
$6.77M Buy
+58,700
New +$6.53M 0.06% 296

Other funds holding CME

Laurion Capital Management's CME Position: Q1 2026 in Review

Laurion Capital Management reduced its CME Group (CME) stake by 4.5% in Q1 2026, selling an estimated $645K and leaving 46,433 shares worth $13.7M. The position accounts for 0.6% of the portfolio, ranked #37.

Laurion Capital Management first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.9M in Q2 2023. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Laurion Capital Management held 46,433 shares of CME Group worth $13.7M as of Q1 2026.
  • Laurion Capital Management sold 2,171 CME Group shares in Q1 2026, an estimated $645K.
  • CME Group made up 0.6% of Laurion Capital Management's portfolio in Q1 2026, its #37 holding.
  • Laurion Capital Management first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • Laurion Capital Management's CME Group position peaked at $18.9M in Q2 2023.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.